Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Avodart

 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Dutasteride
Dutasteride 0.5 MG Oral Capsule [Avodart]Dutasteride Oral Capsule [Avodart]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Solid dispersion of dutasteride using the solvent evaporation method: Approaches to improve dissolution rate and oral bioavailability in rats.
The aim of this study was to develop a dutasteride (DUT) solid dispersion (SD) using hydrophilic substances to enhance its… Expand
Is this relevant?
2014
2014
The Effect of Competing Direct-to-Consumer Advertising Campaigns on the Use of Drugs for Benign Prostatic Hyperplasia: Time Series Analysis
BackgroundDirect-to-consumer advertising (DTCA) remains a controversial issue, with concerns that it leads to unnecessary and… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Pharmacokinetic Bioequivalence Studies of a Fixed-Dose Combination of Tamsulosin and Dutasteride in Healthy Volunteers
Background and ObjectivesThe combination of dutasteride and tamsulosin may be more effective for the treatment of symptomatic… Expand
  • table 1
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2013
2013
MAPPED study design: a 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging.
OBJECTIVE To evaluate the percentage change in volume of prostate cancer, as assessed by T2-weighted MRI, following exposure to… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?
2013
2013
Химиопрофилактика рака предстательной железы у больных доброкачественной гиперплазией предстательной железы с повышенным уровнем простатспецифического антигена
The paper gives the comparative results of chemoprevention against prostate cancer (PC) in 189 patients with benign prostate… Expand
Is this relevant?
2012
2012
Re: clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the…
  • S. Kaplan
  • The Journal of urology
  • 2012
    • Corpus ID: 28080382
Objective: To investigate the influence of baseline variables on the 4-year incidence of acute urinary retention (AUR), benign… Expand
Is this relevant?
2012
2012
Room Temperature Aryl Trifluoromethylation via Copper-Mediated
A method for the room temperature copper-mediated trifluoromethylation of aryl and heteroaryl boronic acids has been developed… Expand
  • figure 1
  • table 2
Is this relevant?
2012
2012
Ask the doctor. I take Avodart for my enlarged prostate. But I heard that Avodart increases prostate cancer risk. Is that true? Should I quit taking Avodart?
  • M. Garnick
  • Harvard health letter
  • 2012
    • Corpus ID: 39165925
 
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4‐year results from the…
What’s known on the subject? and What does the study add? 
Is this relevant?
Review
2005
Review
2005
[Dutasteride (Avodart): a novel 5-alpha reductase inhibitor for treatment of benign prostate hypertrophy].
Dutasteride (Avodart), a novel dual 5-alpha reductase inhibitor is effective for the treatment of benign prostate hypertrophy, of… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE